Wei Wang
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research 128
- MicroRNA in disease regulation 74
- Molecular Biology top 0.5%
- RNA modifications and cancer 82
- Circular RNAs in diseases 62
- Epigenetics and DNA Methylation 53
- Cancer-related gene regulation 37
- RNA Research and Splicing 34
- Oncology top 1%
- Immunology top 2%
- Reproductive Medicine top 2%
-
- Lung Cancer Treatments and Mutations 36
- Co-authors
- Yigang ZengZuowei LiJianxin QiuMing LuoZhihong LiuRobert ShoemakerKun ZhangJie Deng
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei Wang
495 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 4.4k
- Molecular Biology 6.9k
- Oncology 1.8k
- Immunology 1.4k
- Reproductive Medicine 432
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 32 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 15 | |
| 13 | 2021 | 10 | |
| 14 | 2019 | 11 | |
| 15 | 2019 | 30 | |
| 16 | 2018 | 105 | |
| 17 | 2017 | 103 | |
| 18 | 2015 | 43 | |
| 19 | 2015 | 43 | |
| 20 | Influence of Connexin 43 Gene Knockout on the Analgesic Effect of Acupuncture in Visceral Pain Mice | 2008 | 3 |
About Wei Wang
Wei Wang is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 521 papers that have together received 11.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (128 papers), RNA modifications and cancer (82 papers), MicroRNA in disease regulation (74 papers), Circular RNAs in diseases (62 papers), Epigenetics and DNA Methylation (53 papers), Cancer-related gene regulation (37 papers), Lung Cancer Treatments and Mutations (36 papers) and RNA Research and Splicing (34 papers). The work is most often cited by research in Cancer Research (4.4k citations), Molecular Biology (6.9k citations) and Oncology (1.8k citations). Wei Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yigang Zeng, Zuowei Li, Jianxin Qiu, Ming Luo, Zhihong Liu, Robert Shoemaker, Kun Zhang, Jie Deng, Yunping Luo and John W. Whitaker. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, BMC Cancer, Frontiers in Genetics and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.